Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cells
Abstract Checkpoint kinases (CHKs) are involved in the DNA damage response in many cancer cells. CHK inhibitors have been used in clinical trials in combination with chemotherapeutics; however, their effect against bladder cancer remains unclear. Here, we investigated the efficacy of combining gemci...
Saved in:
Main Authors: | , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/961e795ec7d4455493f964a2d9a8fa35 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!